Clozapine and its safety in clinical practice
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F19%3A43877890" target="_blank" >RIV/62157124:16370/19:43877890 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Clozapine and its safety in clinical practice
Original language description
Clozapine represents an irreplaceable therapeutic strategy, particularly in treatment-resistant schizophrenia therapy, which, however, carries certain risk. The aim of the study was to evaluate frequency of clozapine adverse effects in patients with schizophrenia-spectrum disorders hospitalized at Department of Psychiatry, University Hospital Brno, during the period 2012?2014.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů